Published in Am J Pathol on March 01, 1998
Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci U S A (2002) 4.00
Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci U S A (2000) 3.47
Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol (2002) 1.98
Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. Am J Pathol (2000) 1.59
Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF). PLoS One (2009) 1.56
The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system. Am J Pathol (2000) 1.51
The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis. Respir Res (2005) 1.32
Matrix metalloproteinases promote inflammation and fibrosis in asbestos-induced lung injury in mice. Am J Respir Cell Mol Biol (2006) 1.32
A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model. Br J Pharmacol (2010) 1.27
Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease. PLoS One (2013) 1.20
Tissue inhibitor of metalloproteinase-1 deficiency amplifies acute lung injury in bleomycin-exposed mice. Am J Respir Cell Mol Biol (2005) 1.17
Impact of interleukin-13 responsiveness on the synthetic and proliferative properties of Th1- and Th2-type pulmonary granuloma fibroblasts. Am J Pathol (2003) 1.15
Simultaneous transforming growth factor beta-tumor necrosis factor activation and cross-talk cause aberrant remodeling response and myocardial fibrosis in Timp3-deficient heart. J Biol Chem (2009) 1.10
Tissue inhibitor of metalloproteinases 3 regulates resolution of inflammation following acute lung injury. Am J Pathol (2009) 1.10
Collaborative interactions between neutrophil elastase and metalloproteinases in extracellular matrix degradation in three-dimensional collagen gels. Respir Res (2001) 1.02
Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis. J Immunol (2014) 0.97
Developmental regulation and coordinate reexpression of FKBP65 with extracellular matrix proteins after lung injury suggest a specialized function for this endoplasmic reticulum immunophilin. Cell Stress Chaperones (2005) 0.96
Ligand-independent transforming growth factor-β type I receptor signalling mediates type I collagen-induced epithelial-mesenchymal transition. J Pathol (2011) 0.95
Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection. J Virol (2010) 0.95
The selected genetic polymorphisms of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis. Med Sci Monit (2011) 0.92
Macrophage metalloelastase (MMP-12) deficiency does not alter bleomycin-induced pulmonary fibrosis in mice. J Inflamm (Lond) (2006) 0.91
Paracrine functions of fibrocytes to promote lung fibrosis. Expert Rev Respir Med (2014) 0.86
Effect of interleukin-10 and platelet-derived growth factor on expressions of matrix metalloproteinases-2 and tissue inhibitor of metalloproteinases-1 in rat fibrotic liver and cultured hepatic stellate cells. World J Gastroenterol (2004) 0.84
Fra-1/AP-1 transcription factor negatively regulates pulmonary fibrosis in vivo. PLoS One (2012) 0.84
Early activation of pulmonary TGF-β1/Smad2 signaling in mice with acute pancreatitis-associated acute lung injury. Mediators Inflamm (2014) 0.77
Lack of evidence for caveolin-1 and CD147 interaction before and after bleomycin-induced lung injury. Histochem Cell Biol (2006) 0.76
Andrographolide plays an important role in bleomycin-induced pulmonary fibrosis treatment. Int J Clin Exp Med (2015) 0.75
Fistulising Crohn's disease: MMPs gone awry. Gut (2004) 0.75
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
Matrix metalloproteinases: a review. Crit Rev Oral Biol Med (1993) 9.03
Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J (1991) 8.29
Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science (1997) 8.19
Three different fibronectin mRNAs arise by alternative splicing within the coding region. Cell (1983) 6.27
Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet (1990) 5.65
Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J (1987) 4.56
Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci U S A (1996) 2.93
Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Lung Res (1992) 2.57
Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem (1993) 2.56
Mouse macrophage elastase. Purification and characterization as a metalloproteinase. Biochem J (1981) 2.38
The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors. Proc Natl Acad Sci U S A (1986) 2.28
Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J Biol Chem (1989) 2.05
Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J Biol Chem (1997) 2.00
Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem (1994) 1.99
Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem (1996) 1.92
The family of matrix metalloproteinases. Ann N Y Acad Sci (1994) 1.81
Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology (1996) 1.79
The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis (1983) 1.71
Mechanisms of bleomycin-induced lung damage. Arch Toxicol (1991) 1.69
Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs. Biochim Biophys Acta (1991) 1.67
Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am J Pathol (1994) 1.64
Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase. J Biol Chem (1992) 1.57
Unraveling pulmonary fibrosis: the bleomycin model. Lab Invest (1984) 1.56
Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol (1996) 1.40
Molecular cloning of murine 72-kDa type IV collagenase and its expression during mouse development. J Biol Chem (1992) 1.39
High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis. J Pharmacol Exp Ther (1987) 1.39
Murine tissue inhibitor of metalloproteinases-4 (Timp-4): cDNA isolation and expression in adult mouse tissues. FEBS Lett (1997) 1.36
Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts. J Clin Invest (1987) 1.35
Cloning and sequencing of mouse collagenase cDNA. Divergence of mouse and rat collagenases from the other mammalian collagenases. FEBS Lett (1992) 1.31
Profiles of steady state levels of messenger RNAs coding for type I procollagen, elastin, and fibronectin in hamster lungs undergoing bleomycin-induced interstitial pulmonary fibrosis. J Clin Invest (1985) 1.30
Human macrophage metalloelastase. Genomic organization, chromosomal location, gene linkage, and tissue-specific expression. J Biol Chem (1995) 1.30
Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol Ther (1993) 1.29
A growth-responsive gene (16C8) in normal mouse fibroblasts homologous to a human collagenase inhibitor with erythroid-potentiating activity: evidence for inducible and constitutive transcripts. Nucleic Acids Res (1986) 1.25
Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology (1996) 1.24
New perspectives on basic mechanisms in lung disease. 6. Proteinase imbalance: its role in lung disease. Thorax (1993) 1.23
Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe Seyler (1995) 1.18
Susceptibility to experimental interstitial lung disease is modified by immune- and non-immune-related genes. Am Rev Respir Dis (1987) 1.16
Matrix metalloproteases and lung disease. Thorax (1994) 1.13
In situ hybridization analysis of rat lung alpha 1(I) and alpha 2(I) collagen gene expression in pulmonary fibrosis induced by endotracheal bleomycin injection. Lab Invest (1994) 1.12
Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines. J Biol Chem (1992) 1.05
Production of collagenase and tissue inhibitor of metalloproteinases by fibroblasts derived from normal and fibrotic human lungs. Chest (1992) 1.04
Differential regulation of TIMP-1 and TIMP-2 mRNA expression in normal and Ha-ras-transformed murine fibroblasts. Gene (1992) 1.03
Enhanced type III collagen gene expression during bleomycin induced lung fibrosis. Thorax (1993) 1.03
Transforming growth factor beta 1 and cAMP inhibit transcription of epidermal growth factor- and oncogene-induced transin RNA. J Biol Chem (1988) 1.01
The role of cytokines in human lung fibrosis. Monaldi Arch Chest Dis (1996) 1.00
Increased type I procollagen mRNA transcripts in the lungs of mice during the development of bleomycin-induced fibrosis. Eur Respir J (1994) 0.98
The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth. Int J Obes Relat Metab Disord (1996) 0.97
Gene expression of metalloproteinases and their inhibitor in renal tissue of New Zealand black/white F1 mice. Clin Sci (Lond) (1993) 0.82
Temporal expression of tissue inhibitors of metalloproteinases in mouse reproductive tissues during gestation. Mol Reprod Dev (1993) 0.81
Alveolar macrophage secretion of a 92-kDa gelatinase in response to bleomycin. Am J Physiol (1993) 0.80
MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell (1998) 9.70
Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science (1997) 8.19
Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J (2003) 6.23
Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol (1979) 5.94
Idiopathic pulmonary fibrosis. N Engl J Med (2001) 5.49
Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest (2000) 4.90
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med (1999) 4.85
Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest (2000) 4.16
Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med (1998) 4.04
Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med (1981) 4.02
Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke (1998) 3.58
Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am J Med (1981) 3.08
Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci U S A (1996) 2.93
Ciliogenesis and left-right axis defects in forkhead factor HFH-4-null mice. Am J Respir Cell Mol Biol (2000) 2.90
Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci U S A (1999) 2.80
K-ras activation generates an inflammatory response in lung tumors. Oncogene (2006) 2.78
Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem (1991) 2.71
Contribution of monocytes/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardium. Circ Res (2000) 2.66
Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B. J Biol Chem (2001) 2.50
The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell (2000) 2.49
Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis (1997) 2.48
Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest (1998) 2.43
Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med (2000) 2.36
Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc Natl Acad Sci U S A (1981) 2.34
Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization. J Clin Invest (1982) 2.33
Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis (1979) 2.31
Mechanical ventilation with or without 7-day circuit changes. A randomized controlled trial. Ann Intern Med (1995) 2.26
ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J (1999) 2.20
Matrix metalloproteinases in lung biology. Respir Res (2000) 2.18
A randomized, controlled trial of protocol-directed versus physician-directed weaning from mechanical ventilation. Crit Care Med (1997) 2.18
The p38 mitogen-activated protein kinase is required for NF-kappaB-dependent gene expression. The role of TATA-binding protein (TBP). J Biol Chem (1999) 2.11
Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest (1981) 2.10
Determinants of restrictive lung function in asbestos-induced pleural fibrosis. J Appl Physiol (1985) (1990) 2.08
Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung. N Engl J Med (1980) 2.07
Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization. J Clin Invest (1980) 2.04
Clinical role of bronchoalveolar lavage in adults with pulmonary disease. Am Rev Respir Dis (1990) 2.02
Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1994) 2.01
Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J Biol Chem (1997) 2.00
Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis (1983) 1.97
Computer recognition of regional lung disease patterns. Am J Respir Crit Care Med (1999) 1.97
Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase. Science (2000) 1.97
Immunologic reactivity of the lung: the in vivo and in vitro generation of a neutrophil chemotactic factor by alveolar macrophages. Am Rev Respir Dis (1978) 1.97
Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis. Am Rev Respir Dis (1984) 1.96
Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sci U S A (1996) 1.92
Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway inflammation. Am Rev Respir Dis (1987) 1.91
Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis (1987) 1.90
Matrix metalloproteinases generate angiostatin: effects on neovascularization. J Immunol (1998) 1.87
Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin. J Immunol (2001) 1.85
Bronchoalveolar lavage cellularity. The distribution in normal volunteers. Am Rev Respir Dis (1992) 1.81
Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy. Nat Med (2001) 1.81
Elastin fragments attract macrophage precursors to diseased sites in pulmonary emphysema. Science (1981) 1.80
The alveolitis of pulmonary sarcoidosis. Evaluation of natural history and alveolitis-dependent changes in lung function. Am Rev Respir Dis (1983) 1.76
Variable airway responsiveness to inhaled lipopolysaccharide. Am J Respir Crit Care Med (1999) 1.76
Localization of the immune response in sarcoidosis. Am Rev Respir Dis (1979) 1.74
Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest (1994) 1.74
Reversible oxidant-induced increases in albumin transfer across cultured endothelium: alterations in cell shape and calcium homeostasis. Blood (1985) 1.71
Lung inflammation and fibrosis. Am J Respir Crit Care Med (1998) 1.68
Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis (1979) 1.67
Pathogenesis of the granulomatous lung diseases. Am Rev Respir Dis (1984) 1.64
Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J (2002) 1.63
Elastin degradation by matrix metalloproteinases. Cleavage site specificity and mechanisms of elastolysis. J Biol Chem (1997) 1.62
Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol (1998) 1.60
Effect of intermittent high dose parenteral corticosteroids on the alveolitis of idiopathic pulmonary fibrosis. Am Rev Respir Dis (1983) 1.56
Bronchoalveolar lavage of allergic asthmatic patients following allergen bronchoprovocation. Chest (1986) 1.53
Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology (1998) 1.53
Normal neutrophil function in cathepsin G-deficient mice. Blood (1999) 1.53
The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats. J Biol Chem (1996) 1.53
Chronic obstructive pulmonary disease * 3: Experimental animal models of pulmonary emphysema. Thorax (2002) 1.51
Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease. Inflamm Res (2005) 1.50
The clinical utility and reliability of asbestos bodies in bronchoalveolar fluid. Am Rev Respir Dis (1991) 1.47
Both Erk and p38 kinases are necessary for cytokine gene transcription. Am J Respir Cell Mol Biol (1999) 1.47
Modulation of interleukin 1 beta gene expression by the immediate early genes of human cytomegalovirus. J Clin Invest (1990) 1.46
End-stage chronic obstructive pulmonary disease: the cigarette is burned out but inflammation rages on. Am J Respir Crit Care Med (2001) 1.45
Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling. Biochem J (1999) 1.45
Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. Arthritis Rheum (1996) 1.45
Oxidant injury of lung parenchymal cells. J Clin Invest (1981) 1.44
Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-kappa B and NF-IL-6. J Infect Dis (1996) 1.44
Deletions of the long arm of chromosome 10. Am J Med Genet (1985) 1.44
Immunological reactivity of the lung. I. A guinea pig model for the study of pulmonary mononuclear cell subpopulations. Cell Immunol (1976) 1.43
Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am Rev Respir Dis (1981) 1.42
Correlation of chest roentgenograms with pulmonary function and bronchoalveolar lavage in interstitial lung disease. Chest (1989) 1.42
Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes. J Clin Invest (1981) 1.41
Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window. Brain Res (1995) 1.40
High-resolution CT-derived measures of lung density are valid indexes of interstitial lung disease. J Appl Physiol (1985) (1994) 1.40
Regulation of the release of alveolar macrophage-derived neutrophil chemotactic factor. Am Rev Respir Dis (1980) 1.37
Guidelines for the clinical evaluation of hypersensitivity pneumonitis. Report of the Subcommittee on Hypersensitivity Pneumonitis. J Allergy Clin Immunol (1989) 1.35
Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies, and bronchoalveolar lavage. Am Rev Respir Dis (1981) 1.35
Developmental expression of latent transforming growth factor beta binding protein 2 and its requirement early in mouse development. Mol Cell Biol (2000) 1.34
Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. J Immunol (1991) 1.34
Intraoral findings and anomalies in neonates. Pediatrics (1982) 1.32
Interstitial lung disease: A quantitative study using the adaptive multiple feature method. Am J Respir Crit Care Med (1999) 1.32
Low grade rhinovirus infection induces a prolonged release of IL-8 in pulmonary epithelium. J Immunol (1998) 1.31
Interferon-gamma is necessary for the expression of hypersensitivity pneumonitis. J Clin Invest (1997) 1.31
Prognostic role of eosinophils in pulmonary fibrosis. Chest (1987) 1.30
Role of interleukin-2 release by lung T-cells in active pulmonary sarcoidosis. Am Rev Respir Dis (1983) 1.30
Human macrophage metalloelastase. Genomic organization, chromosomal location, gene linkage, and tissue-specific expression. J Biol Chem (1995) 1.30
A critical role for neutrophil elastase in experimental bullous pemphigoid. J Clin Invest (2000) 1.30
Lipopolysaccharide-induced NF-kappaB activation and cytokine release in human alveolar macrophages is PKC-independent and TK- and PC-PLC-dependent. Am J Respir Cell Mol Biol (1998) 1.29
Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation. J Biol Chem (2000) 1.29
Determinants of progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1994) 1.27